AI-generated · cited to primary sources · not investment advice
Quick Heal Tech (539678) Oct 2025 Filing Analysis
Does management do what it says?
Management has successfully maintained its market leadership with a share of over 30% in the Indian market. (2 met, 1 in progress across 3 tracked commitments)
“Market leadership with over 30% in the Indian market ... Focus towards maintaining our market share in AV segment”
The revenue mix is rapidly shifting toward Enterprise, which now accounts for 45% of the business in 9M FY2026, up from 40% in FY2025 and 20% in FY2021. (1 in progress, 1 met across 2 tracked commitments)
“Mid-market when I say, it's like organizations who have more than 1,000 endpoints, less than 5,000 endpoints, so somewhere that... In that we are focused on our XDR and ZTNA products and zero-trust products to sell them.”
The company missed its target of 40% cloud-based revenue for the enterprise segment by Q1 FY2026. As of H1 FY2026, the cloud mix stands at 37%, although it has improved from 31% in FY25. (2 missed, 1 met, 1 in progress across 4 tracked commitments)
“So, we are continuously progressing the direction where very soon, our Enterprise business will take over the Consumer business.”
Despite the commitment to improve margins, EBITDA margins for 9M FY26 fell to 0.0% compared to 0.9% in 9M FY25, and Gross Margins slightly declined from 97.1% to 97.0%. (2 missed across 2 tracked commitments)
“But as we grow, as the number will go up, these margins will certainly improve.”
Fulfillment of a large INR 64 Cr order for integrated cybersecurity solutions over a 5-year period. — target: INR 64 Cr (+1 more commitment)
“So, all put together, over the 2 to 3 years, our SOM be around INR 4,000 crores as a total market, and we want to grab as much as possible.”
See the full cited Management analysis of Quick Heal Tech
How durable is the business?
The company has launched a new growth lever focused on Data Privacy, securing its first order for the Seqrite Data Privacy product, likely driven by upcoming Indian regulations. (2 new, 1 expanding, 1 shifted)
“First Order received for Seqrite Data Privacy”
See the full cited Business Model analysis of Quick Heal Tech
Where does growth come from?
The company has identified a massive expansion in its addressable market to INR 4,000 crores over the next 2-3 years, specifically targeting the 'Make in India' preference in government and mid-market segments. (2 new trend across 2 signals)
“So, all put together, over the 2 to 3 years, our SOM be around INR 4,000 crores as a total market, and we want to grab as much as possible.”
See the full cited Future Growth analysis of Quick Heal Tech
What could break the thesis?
The trajectory is STABLE to improving; Enterprise now represents 40% of the business (up from 20% four years ago) and is growing steadily with a focus on the mid-market (1,000-5,000 endpoints). (1 stable)
“4 years back, our Consumer business was 18% and our Enterprise business 20%. But over the last couple of quarters, now it is 60-40.”
See the full cited Risk analysis of Quick Heal Tech
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.